by John Conrad | Oct 3, 2024 | Member News
Eli Lilly and Company, a leading pharmaceutical giant, has announced plans to invest $4.5 billion in a groundbreaking new facility aimed at revolutionizing drug production and accelerating the development of medicines for clinical trials. The announcement comes as...
